Cannabis Use, Cannabis Use Disorder Are Not The Same
Cannabis use and cannabis use disorder showed partly different genetic relationships with selected brain-imaging traits in a large 2026 analysis. The findings support treating use and disorder as related but noninterchangeable research phenotypes. They…
Cannabinoids for MS Spasticity: What 27 Randomized Trials Show
cannabinoids for MS spasticity: A systematic review of 27 randomized trials found modest patient-reported improvement in multiple-sclerosis spasticity, especially with THC:CBD extracts. Objective benefits were limited and the certainty of evidence was…
Cannabis Use With GLP-1 Therapy: What a Diabetes Cohort Found
Cannabis and GLP-1 therapy were examined in a matched cohort of 8,234 adults with type 2 diabetes. Cannabis-related diagnosis codes were associated with higher mortality, cardiovascular events, and kidney events. The retrospective design raises a safety…
Prenatal Cannabis Use and Motivation to Quit: What a New Study Found
prenatal cannabis use: A study of 176 pregnant adults found that several motivation measures were associated with less self-reported cannabis use. The secondary observational analysis cannot show that motivation or a specific intervention caused reduced…
FAA Initiates Cannabis Rescheduling Review for Pilot Fitness-for-Duty
The FAA cannabis rescheduling pilot fitness-for-duty review is underway, examining how federal rescheduling affects drug testing and certification for pilots and air traffic controllers. This process will inform future FAA cannabis policies but does not…
CED Cannabis Science Digest: CBD and Macrophage Inflammation, Texas Compassionate Use Access
CBD macrophage inflammation: A controlled human cell-culture study found CBD selectively reduced part of the inflammatory response in lipid-stressed macrophages, and a separate policy analysis argues Texas should add dialysis patients as a qualifying…
UK Medical Cannabis Use: What a New National Survey Found
A new UK national survey examined uk medical cannabis prescriptions and their link to high-risk use. The study found prescribed users more frequently used processed products and screened positive for high-risk use. These findings highlight the need for…
The DEA Rescheduling Hearing Is Over. States Should Lead Cannabis Research
State-led cannabis research infrastructure: The DEA rescheduling hearing concluded in July 2026, marking a procedural milestone. Experts argue that the clinical benefits of rescheduling depend on states building dedicated cannabis research…
THC-Dominant Edibles and Chronic Low Back Pain: What a New Real-World Study Found
Thc dominant edible cannabis chronic low back pain: This study examines THC dominant edible cannabis and its association with lower daily pain intensity in adults with chronic low back pain. Findings suggest THC dominant products correlate with reduced…
Cannabinoids and Cognitive Function in Bipolar Disorder: What a New Study Found
A new study on cannabinoids cognition bipolar disorder examined whether cannabis use correlates with improved timing and attention in people with bipolar disorder. Chronic cannabis users performed similarly to healthy adults, and an acute THC challenge…